British regulators on Thursday said they have identified 30 cases of rare blood clot events after the use of the AstraZeneca-Oxford COVID-19 vaccine, 25 more than the agency previously reported.
British regulators increase number of blood clot cases after AstraZeneca vaccine to 30
